戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 by (18)F-FDG accumulated in tumors to induce photoimmunotherapy.
2  without compromising therapeutic effects of photoimmunotherapy.
3 ial histologic analyses were conducted after photoimmunotherapy.
4 as reduced by more than 99% within 1 h after photoimmunotherapy.
5 immunoconjugate uptake as a way of enhancing photoimmunotherapy.
6 d with intact IgG for their effectiveness as photoimmunotherapy agents.
7 one of tumors changed size within 24 h after photoimmunotherapy, although diffuse necrosis was observ
8 treated tumors decreased 76% at 75 min after photoimmunotherapy and did not change for 24 h.
9 ultiepitope targeting enhances HER2-targeted photoimmunotherapy and maintains a high degree of specif
10 eight of the tumors in the mice treated with photoimmunotherapy, and the median survival increased fr
11 or monitoring the acute cytotoxic effects of photoimmunotherapy before the tumor begins to shrink, we
12 cal assessment of the therapeutic effects of photoimmunotherapy earlier than anatomic methods that re
13                                     To date, photoimmunotherapy has been demonstrated only with full
14 ese concepts of "tumor-targeted, activatable photoimmunotherapy" in a mouse model of peritoneal carci
15                                              Photoimmunotherapy induces rapid and highly specific nec
16                                              Photoimmunotherapy is a highly cell-selective cancer the
17                                              Photoimmunotherapy may allow targeted photodynamic destr
18                                Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment t
19                                Near infrared photoimmunotherapy (NIR-PIT), a targeted cancer therapy
20 uggest cationic PICs may have advantages for photoimmunotherapy of disseminated intracavity cancer fo
21                                              Photoimmunotherapy (PIT) is an emerging low side effect
22 ugate for combined fluorescent detection and photoimmunotherapy (PIT) of CD44 expressing cells in TNB
23 w type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific ph
24          Antibody-based photodynamic therapy-photoimmunotherapy (PIT)-is an ideal modality to improve
25 y (mAb)-based, highly specific phototherapy (photoimmunotherapy; PIT) that uses a near infrared (NIR)
26    Consequently, it seems that multitargeted photoimmunotherapy should also be useful against cancers
27                                              Photoimmunotherapy shows efficacy in destroying liver tu
28 y, although diffuse necrosis was observed in photoimmunotherapy-treated tumors.
29                                              Photoimmunotherapy (using a monoclonal antibody-targeted
30   The uptake of (18)F-FDG in the tumor after photoimmunotherapy was evaluated in cellular uptake stud
31                 Then therapeutic efficacy of photoimmunotherapy was examined by exposing mice to NIR
32                                              Photoimmunotherapy was performed by binding panitumumab
33       Immediate cytotoxic effects induced by photoimmunotherapy were clearly detected by decreased gl
34 ecently developed a cancer-specific therapy, photoimmunotherapy, which uses an antibody-IR700 (photot
35                              A comparison of photoimmunotherapy with 10 J of light delivered at 30 or
36                        Multiepitope targeted photoimmunotherapy with a HER50 and HER66 photosensitize
37  more effective than single-epitope targeted photoimmunotherapy with a single anti-HER2 photosensitiz
38                                              Photoimmunotherapy with the same molar concentration of

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。